UNSPSC 51401505: Alprazolam

This classification denotes a benzodiazepine with the molecular formula C17H13ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YU55MQ3IZY, chemically known as 8-chloro-1-methyl-6-phenyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepine but generally known as alprazolam, which bears US NIH Compound Identifier 2118. Alprazolam most often comes in base and dihydrate forms. European Medicines Agency schedules Alprazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05370MIG.

UNSPSC 51401505 Alprazolam is a Commodity code, but the recent state and local procurement activity under this code shows minimal relevant activity. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, for the procurement of Naloxone and Safe Drug Deactivation Systems — not alprazolam — creating a clear mismatch between the code's nominal scope and the work actually being solicited. The county is seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs in proposals, and comply with drug-free workplace certification and E-Verify requirements. The initial contract term is two years with an option for one-year renewal, subject to a three-month probationary period. The procurement notes potential FEMA funding with attendant federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Beyond this single solicitation, the source supports no other recent state and local opportunities tagged to this code.

The geographic activity is limited to Florida based on available records. With only one recent opportunity visible and a fundamental categorical mismatch between the code name (alprazolam, a prescription anxiolytic) and the goods actually being procured (naloxone reversal agents and drug deactivation systems), this code shows little active state and local procurement momentum for its stated scope. Business development professionals evaluating this code should verify whether alprazolam procurement activity exists under a different code classification or whether state and local demand for this pharmaceutical remains minimal in current solicitation pipelines.